Paper1908882
Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
Kabat EA and 1 other. J Immunol, 1991. Cited by 294 papers, by iCite.
Cite this record
ConductScience Library. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. Papers, record 1908882. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1908882
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
- PubMed
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Specificity | Major topic |
| Binding Sites, Antibody | Major topic |
| Genes, Immunoglobulin | Major topic |
| Immunoglobulin Heavy Chains | Major topic |
| Immunoglobulin Light Chains | Major topic |
| Immunoglobulin Variable Region | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Guinea Pigs | |
| Humans | |
| Mice | |
| Molecular Sequence Data | |
| Protein Conformation | |
| Rabbits | |
| Rats |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 3RO1-AI-27508 | NIAID NIH HHS | United States | R01AI027508 | PubMed and NIH | NIH RePORTER |
| 5RO1-AI-125616 | NIAID NIH HHS | United States | RO1AI125616 | PubMed | NIH RePORTER |
Cited by118
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 294 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42253975 | Engineering strategies and binding mechanisms of therapeutic anti-PD-1 antibodies approved by regulatory agencies globally. | Front Immunol | 2026 | https://conductscience.org/library/papers/42253975 | PubMed |
| 41310398 | Using phage display for rational engineering of a higher-affinity humanized 3' phosphohistidine-specific antibody. | Commun Chem | 2025 | https://conductscience.org/library/papers/41310398 | PubMed |
| 40864052 | A Novel Anti-BoNT/A Neutralizing Antibody Possessed Overlapped Epitope with SV2 and Had Prolonged Half-Life In Vivo. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40864052 | PubMed |
| 40843683 | Guidelines in the Preparation of Fully Synthetic, Human Single-Domain Antibody Phage Display Libraries. | Antibodies (Basel) | 2025 | https://conductscience.org/library/papers/40843683 | PubMed |
| 39381136 | The process using a synthetic library that generates multiple diverse human single domain antibodies. | Antib Ther | 2024 | https://conductscience.org/library/papers/39381136 | PubMed |
| 39289783 | Sequence-based engineering of pH-sensitive antibodies for tumor targeting or endosomal recycling applications. | MAbs | 2024 | https://conductscience.org/library/papers/39289783 | PubMed |
| 38997490 | Structural Characterization of Peptide Antibodies. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/38997490 | PubMed |
| 38963938 | Identification of heparin-binding amino acid residues in antibody HS4C3 with the potential to design antibodies against heparan sulfate domains. | Glycobiology | 2024 | https://conductscience.org/library/papers/38963938 | PubMed |
| 36298728 | Exploiting V-Gene Bias for Rapid, High-Throughput Monoclonal Antibody Isolation from Horses. | Viruses | 2022 | https://conductscience.org/library/papers/36298728 | PubMed |
| 36278614 | Yeast Surface Display Platform for Rapid Selection of an Antibody Library via Sequential Counter Antigen Flow Cytometry. | Antibodies (Basel) | 2022 | https://conductscience.org/library/papers/36278614 | PubMed |
| 35906512 | Imaging the Alternatively Spliced D Domain of Tenascin C in a Preclinical Model of Inflammatory Bowel Disease. | Mol Imaging Biol | 2023 | https://conductscience.org/library/papers/35906512 | PubMed |
| 35538099 | Profiling of hMPV F-specific antibodies isolated from human memory B cells. | Nat Commun | 2022 | https://conductscience.org/library/papers/35538099 | PubMed |
| 35157279 | Humanization of Camelid Single-Domain Antibodies. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35157279 | PubMed |
| 34753944 | A site of vulnerability at V3 crown defined by HIV-1 bNAb M4008_N1. | Nat Commun | 2021 | https://conductscience.org/library/papers/34753944 | PubMed |
| 34524888 | Development of a Nanobody-Based Competitive Enzyme-Linked Immunosorbent Assay for Efficiently and Specifically Detecting Antibodies against Genotype 2 Porcine Reproductive and Respiratory Syndrome Viruses. | J Clin Microbiol | 2021 | https://conductscience.org/library/papers/34524888 | PubMed |
| 34390413 | Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method. | Med Oncol | 2021 | https://conductscience.org/library/papers/34390413 | PubMed |
| 33482061 | Chemical Diversification of Simple Synthetic Antibodies. | ACS Chem Biol | 2021 | https://conductscience.org/library/papers/33482061 | PubMed |
| 32991803 | Computational Investigation of Gantenerumab and Crenezumab Recognition of Aβ Fibrils in Alzheimer's Disease Brain Tissue. | ACS Chem Neurosci | 2020 | https://conductscience.org/library/papers/32991803 | PubMed |
| 32880207 | Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action. | MAbs | 2020 | https://conductscience.org/library/papers/32880207 | PubMed |
| 32640530 | Epitope Mapping and Computational Analysis of Anti-HPV16 E6 and E7 Antibodies in Single-Chain Format for Clinical Development as Antitumor Drugs. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32640530 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MLC1 | 23209 | PubTator's text mining | https://conductscience.org/library/genes/23209 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1908882
GET https://conductscience.org/api/papers/v1/1908882/cited_by?page=2